2006
DOI: 10.1093/ptj/86.5.698
|View full text |Cite
|
Sign up to set email alerts
|

Transcutaneous Electrical Nerve Stimulation for the Management of Neuropathic Pain: The Effects of Frequency and Electrode Position on Prevention of Allodynia in a Rat Model of Complex Regional Pain Syndrome Type II

Abstract: Background and Purpose. Complex regional pain syndrome type II (CPSII) is a painful condition that develops following a nerve injury. Although transcutaneous electrical nerve stimulation (TENS) relieves the pain of CPSII, the stimulation parameters that would best prevent the development of the condition are not known. The purpose of this study was to compare the ability of several different stimulation strategies to reduce the development of allodynia. Subjects. Sprague-Dawley rats were used in the study. Met… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
46
0
1

Year Published

2007
2007
2021
2021

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 73 publications
(48 citation statements)
references
References 65 publications
1
46
0
1
Order By: Relevance
“…Also, TENS is usually employed to control neuropathic pain ( Leem et al, 1995; Hanai, 2000; Nam et al, 2001; Cheing and Luk, 2005; Somers and Clemente, 1998; 2003; 2006 ) , which is often associated with peripheral nerve lesions and sometimes WD ( Latinovic et al, 2006 ) . TENS analgesic effects are related to the release of endogenous opioids ( Sluka and Walsh, 2003 ) ; this is related to another controversy on its use to improve nerve regeneration because chronic opioid exposure may be associated with tolerance and inhibition of various steps of the peripheral nerve restoration process ( Smith and Hui, 1973; Sinatra and Ford, 1979; Sinatra et al, 1979; Zeng et al, 2007 ) .…”
Section: Introductionmentioning
confidence: 99%
“…Also, TENS is usually employed to control neuropathic pain ( Leem et al, 1995; Hanai, 2000; Nam et al, 2001; Cheing and Luk, 2005; Somers and Clemente, 1998; 2003; 2006 ) , which is often associated with peripheral nerve lesions and sometimes WD ( Latinovic et al, 2006 ) . TENS analgesic effects are related to the release of endogenous opioids ( Sluka and Walsh, 2003 ) ; this is related to another controversy on its use to improve nerve regeneration because chronic opioid exposure may be associated with tolerance and inhibition of various steps of the peripheral nerve restoration process ( Smith and Hui, 1973; Sinatra and Ford, 1979; Sinatra et al, 1979; Zeng et al, 2007 ) .…”
Section: Introductionmentioning
confidence: 99%
“…Both high-frequency (hi) and low-frequency (lo) TENS are used to treat neuropathic pain patients. hi teNs affects muscarinic receptors through a µ-opioid receptor-dependent mechanism, and lF TENS treatments alleviate secondary allodynia through serotonergic, muscarinic, and µ-opioid receptor-dependent mechanisms (28,29). Norrbrink (29) investigated the effectiveness of lo and hi TENS in 24 ScI patients, and found that neither current type significantly improved the pain intensity ratings.…”
Section: Discussionmentioning
confidence: 99%
“…101 In a later study, these researchers demonstrated that TENS applied contralaterally to the nerve injury reduced the development of allodynia following the nerve-constriction injury. 99 In a third study, they showed that contralateral TENS elevated the inhibitory neurotransmitter GABA bilaterally in the dorsal horn and also reduced mechanical allodynia on the side of the nerve-constriction injury. 100 GABA plays a key role in mediating antinociception in the spinal cord.…”
Section: Animal Models Of Painmentioning
confidence: 96%
“…In a series of studies, Somers et al evaluated the physiological and analgesic effects of TENS in rats with a chronic nerve-constriction injury, which is a model for neuropathic pain. [98][99][100] They showed that daily conventional TENS on the same side as the nerve injury reduced bilateral dorsal horn content of aspartate and glutamate compared to untreated rats. 98 These excitatory neurotransmitters play a key role in the development and maintenance of neuropathic pain.…”
Section: Animal Models Of Painmentioning
confidence: 99%